MicroPort Scientific Corporation announced an update on the renewal of its purpose-built industrial facility in the China (Shanghai) Pilot Free Trade Zone.

Key points • Existing lease framework: In May 2021, ten lease agreements covering 126,370 sqm were signed with landlord BlueOrange Capital for a five-year term (1 Aug 2021 – 31 Jul 2026) at an aggregate rent of USD 194.66 million, with security deposits equivalent to one or two years’ rent. • Current renewal progress:  – Three subsidiaries—Shanghai MicroPort CardioFlow Medtech, MicroPort Soaring CRM (Shanghai), and Shanghai Yuanxin Medtech—have secured new leases totaling 13,872.64 sqm, each expiring on 31 Jul 2031.  – Eight additional subsidiaries are negotiating terms for a further 74,686.84 sqm. Outstanding items include unit rent, total consideration and updated security-deposit arrangements. • Deposits in place: As of the announcement date, the Group maintains RMB 295.99 million in deposits with BlueOrange Capital. The subsidiaries continue occupying the premises while negotiations proceed. • Next steps: Definitive agreements for the remaining space may trigger disclosure obligations under the Hong Kong Listing Rules; further announcements will be made when terms are finalised.

Shareholders and potential investors are advised that the proposed leases have not yet been concluded, and discussions may or may not result in binding agreements.